Cargando…

Perspective of HLA-G Induced Immunosuppression in SARS-CoV-2 Infection

COVID-19, the disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has threatened public health worldwide. Host antiviral immune responses are essential for viral clearance and disease control, however, remarkably decreased immune cell numbers and exhaustion of host cellul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Aifen, Yan, Wei-Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685204/ https://www.ncbi.nlm.nih.gov/pubmed/34938296 http://dx.doi.org/10.3389/fimmu.2021.788769

Ejemplares similares

The Role of HLA-G in Human Papillomavirus Infections and Cervical Carcinogenesis
por: Xu, Hui-Hui, et al.
Publicado: (2020)

Heterogeneity of HLA-G Expression in Cancers: Facing the Challenges
por: Lin, Aifen, et al.
Publicado: (2018)

HLA-G/ILTs Targeted Solid Cancer Immunotherapy: Opportunities and Challenges
por: Lin, Aifen, et al.
Publicado: (2021)

Intratumor Heterogeneity of HLA-G Expression in Cancer Lesions
por: Zhang, Xia, et al.
Publicado: (2020)

Innate and adaptive immune response in SARS-CoV-2 infection-Current perspectives
por: Zhu, Qiugang, et al.
Publicado: (2022)

The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
por: Zhang, Yun-yu, et al.
Publicado: (2020)

Perspective: Reducing SARS-CoV2 Infectivity and Its Associated Immunopathology
por: Dubey, Abhishek, et al.
Publicado: (2020)

Induction of pulmonary HLA-G expression by SARS-CoV-2 infection
por: Seliger, Barbara, et al.
Publicado: (2022)

HLA-C dysregulation as a possible mechanism of immune evasion in SARS-CoV-2 and other RNA-virus infections
por: Loi, Eleonora, et al.
Publicado: (2022)

Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection
por: Liang, Yanwen, et al.
Publicado: (2020)

Intercellular transfer of HLA‐G: its potential in cancer immunology
por: Lin, Aifen, et al.
Publicado: (2019)

Prognostic Significance of Immune Checkpoints HLA-G/ILT-2/4 and PD-L1 in Colorectal Cancer
por: Chen, Qiong-Yuan, et al.
Publicado: (2021)

NVX-CoV2373-induced T- and B-cellular immunity in immunosuppressed people with multiple sclerosis that failed to respond to mRNA and viral vector SARS-CoV-2 vaccines
por: Mueller-Enz, Magdalena, et al.
Publicado: (2023)

Current HLA Investigations on SARS-CoV-2 and Perspectives
por: Douillard, Venceslas, et al.
Publicado: (2021)

Defending against SARS-CoV-2: The T cell perspective
por: Almendro-Vázquez, Patricia, et al.
Publicado: (2023)

Cannabidiol and SARS-CoV-2 Infection
por: Vallée, Alexandre
Publicado: (2022)

Immunosuppression and SARS-CoV-2 breakthrough infections
por: Kim, Alfred H J, et al.
Publicado: (2022)

Impact of peptide:HLA complex stability for the identification of SARS-CoV-2-specific CD8(+)T cells
por: Lie-Andersen, Olivia, et al.
Publicado: (2023)

The IgG glycome of SARS-CoV-2 infected individuals reflects disease course and severity
por: Siekman, Sterre L., et al.
Publicado: (2022)

CD8(+) T Cells in SARS-CoV-2 Induced Disease and Cancer—Clinical Perspectives
por: Mortezaee, Keywan, et al.
Publicado: (2022)

Role of HLA-G in Viral Infections
por: Jasinski-Bergner, Simon, et al.
Publicado: (2022)

Therapy Targets SARS-CoV-2 Infection-Induced Cell Death
por: Zhu, Zhoujie, et al.
Publicado: (2022)

Overlapping but Disparate Inflammatory and Immunosuppressive Responses to SARS-CoV-2 and Bacterial Sepsis: An Immunological Time Course Analysis
por: Loftus, Tyler J., et al.
Publicado: (2021)

Association between immunosuppressants and poor antibody responses to SARS-CoV-2 vaccines in patients with autoimmune liver diseases
por: Li, Hu, et al.
Publicado: (2022)

Serum IgG anti-SARS-CoV-2 Binding Antibody Level Is Strongly Associated With IgA and Functional Antibody Levels in Adults Infected With SARS-CoV-2
por: Ye, Xunyan, et al.
Publicado: (2021)

Investigation of Extracellular Vesicles From SARS-CoV-2 Infected Specimens: A Safety Perspective
por: Nunez Lopez, Yury O., et al.
Publicado: (2021)

Editorial: The Biological and Clinical Aspects of HLA-G
por: LeMaoult, Joel, et al.
Publicado: (2021)

Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses
por: Abdelrahman, Zeinab, et al.
Publicado: (2020)

The KIR2DL2/HLA-C1C1 Gene Pairing Is Associated With an Increased Risk of SARS-CoV-2 Infection
por: Hu, Song, et al.
Publicado: (2022)

Comprehensive Comparison of RNA-Seq Data of SARS-CoV-2, SARS-CoV and MERS-CoV Infections: Alternative Entry Routes and Innate Immune Responses
por: Cao, Yingying, et al.
Publicado: (2021)

Effects of SARS-CoV-2 Alpha, Beta, and Delta variants, age, vaccination, and prior infection on infectiousness of SARS-CoV-2 infections
por: Qassim, Suelen H., et al.
Publicado: (2022)

The effect of immunosuppressants on the prognosis of SARS-CoV-2 infection
por: Ward, Daniel, et al.
Publicado: (2022)

HLA-G/sHLA-G and HLA-G-Bearing Extracellular Vesicles in Cancers: Potential Role as Biomarkers
por: Li, Peilong, et al.
Publicado: (2021)

Follicular Helper T Cells in the Immunopathogenesis of SARS-CoV-2 Infection
por: Cui, Dawei, et al.
Publicado: (2021)

HLA-G Molecules in Autoimmune Diseases and Infections
por: Rizzo, Roberta, et al.
Publicado: (2014)

Identification of Novel Candidate Epitopes on SARS-CoV-2 Proteins for South America: A Review of HLA Frequencies by Country
por: Requena, David, et al.
Publicado: (2020)

Influence of HLA Class II Polymorphism on Predicted Cellular Immunity Against SARS-CoV-2 at the Population and Individual Level
por: Copley, Hannah C., et al.
Publicado: (2021)

A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta
por: Carter, Brandon, et al.
Publicado: (2023)

Immunosuppressant Treatment in Rheumatic Musculoskeletal Diseases Does Not Inhibit Elicitation of Humoral Response to SARS-CoV-2 Infection and Preserves Effector Immune Cell Populations
por: Favalli, Andrea, et al.
Publicado: (2022)

SARS-CoV-2 infection dysregulates NAD metabolism
por: Izadpanah, Amin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k6s45bbv7ni58p9k5jj52dge3a